Feb 6 (Reuters)-
Zeria Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2017 Dec 31, 2016 Mar 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 49.64 49.04 66.00
(+1.2 pct) (+4.2 pct) (+1.8 pct)
Operating 4.59 3.64 5.00
(+26.0 pct) (-4.0 pct) (+10.1 pct)
Recurring 4.89 3.50 5.20
(+39.6 pct) (-7.0 pct) (+17.2 pct)
Net 3.96 2.87 4.10
(+37.6 pct) (-13.8 pct) (+15.7 pct)
EPS 76.35 yen 54.10 yen 79.53 yen
Ann Div 32.00 yen 34.00 yen
-Q2 div 17.00 yen 16.00 yen
-Q4 div 16.00 yen 17.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T
((Tokyo Headline News Desk +813 6441 1812))